Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
NCT ID: NCT05533840
Last Updated: 2022-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1500 participants
OBSERVATIONAL
2022-09-30
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Imaging of Tinnitus
NCT00359931
Reliability of a Portable Audiometric Device Based on Active Noise-Canceling Headphones for Clinical Hearing Assessment
NCT06811610
Cone Beam CT for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose
NCT01855425
PET-CT-based Study of Central Mechanisms of Cortical Metabolism in 18F-FDG and 18F-AV1451 Age-related Deafness
NCT05796011
Cone-beam CT in the Diagnosis and Surgical Treatment of Otosclerosis.
NCT05921578
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Age under 18
Participants under the age of 18
ultra-high-resolution computed tomography exams
Participants in the age groups undergo ultra-high-resolution computed tomography exam
Age 18-30
Participants aged 18-30
ultra-high-resolution computed tomography exams
Participants in the age groups undergo ultra-high-resolution computed tomography exam
Age 31-40
Participants aged 31-40
ultra-high-resolution computed tomography exams
Participants in the age groups undergo ultra-high-resolution computed tomography exam
Age 41-50
Participants aged 41-50
ultra-high-resolution computed tomography exams
Participants in the age groups undergo ultra-high-resolution computed tomography exam
Age 51-60
Participants aged 51-60
ultra-high-resolution computed tomography exams
Participants in the age groups undergo ultra-high-resolution computed tomography exam
Age ≥61
Participants aged ≥61
ultra-high-resolution computed tomography exams
Participants in the age groups undergo ultra-high-resolution computed tomography exam
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultra-high-resolution computed tomography exams
Participants in the age groups undergo ultra-high-resolution computed tomography exam
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Can cooperate to complete U-HRCT examination
* There is no relevant medical history in the side ear scanned
* Due to tinnitus/deafness/peripheral vertigo/peripheral facial paralysis in the ENT department of our hospital
* Meet the ethical requirements of U-HRCT examination
* Can cooperate with the completion of U-HRCT examination
* Surgery in the ENT department of our hospital
* At least one follow-up or re-examination after discharge
Exclusion Criteria
* Congenital inner ear malformation
* Diseases causing bone changes around the middle and inner ear, such as otitis media, tumors , otosclerosis, fibrous dysplasia, etc.
* history of previous ear surgery and trauma
* CT image artifacts or incomplete scan coverage
* incomplete clinical data
2. For patients with otological diseases
* History of previous ear surgery and trauma
* CT image artifacts or incomplete scanning coverage
* Incomplete clinical data
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Tongren Hospital
OTHER
Beijing Obstetrics and Gynecology Hospital
OTHER
Beijing Friendship Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wang, Zhenchang
Vice President, Director of Medical Imaging Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhenchang Wang, Prof.
Role: PRINCIPAL_INVESTIGATOR
Beijing Friendship Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-1-1111
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.